Background: The rate of disease progression among per-sons infected wi th human immunodeficiency virus type 1 (HIV-1) varies widely, and the relative prognostic value of markers of disease activity has not been defined. Objective: To compare clinical, serologic, cellular, and virologic markers for their ability to predict progression to the acquired immunodeficiency syndrome (AIDS) and death during a 10-year period. Design: Prospective, multicenter cohort study. Setting: Four university-based clinical centers participat
DEPLETION OF CD4 CELLS IS Ahallmark of progressive hu-man immunodeficiency vi-rus (HIV) disease1 and...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
Background: Measures of CD4 T-cell count and HIV-1 plasma viral load before antiretroviral therapy a...
Objective. To compare the prognostic ability of first available measurements of CD4 cell count and v...
Virologic measurements are increasingly used to evaluate prognosis and treatment responses in human ...
Infection with the human immunodeficiency virus type 1 (HIV-1) results in a severe immunodeficiency ...
BackgroundOpportunistic infections are an important cause of morbidity and mortality in persons infe...
Infection with the human immunodeficiency virus (HIV-1) results in a severe immunodeficiency charact...
The prognostic value of CD4 counts and RNA viral load for identifying treatment need in HIV-infected...
Background: Markers are needed for assessing response to antiretroviral therapy over t ime. The CD4+...
Human immunodeficiency virus (HIV)-1 DNA and RNA levels and T lymphocyte cell surface markers were m...
The causal relationship between HIV-specific CD4+ T-cell responses and viral control and the effect ...
textabstractBackground: The prognostic value of CD4 counts and RNA viral load for identifying treatm...
Background. Variability in human immunodeficiency virus (HIV) disease progression cannot be fully pr...
This paper is aimed at providing a comprehensive review of markers, cofactors and staging systems us...
DEPLETION OF CD4 CELLS IS Ahallmark of progressive hu-man immunodeficiency vi-rus (HIV) disease1 and...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
Background: Measures of CD4 T-cell count and HIV-1 plasma viral load before antiretroviral therapy a...
Objective. To compare the prognostic ability of first available measurements of CD4 cell count and v...
Virologic measurements are increasingly used to evaluate prognosis and treatment responses in human ...
Infection with the human immunodeficiency virus type 1 (HIV-1) results in a severe immunodeficiency ...
BackgroundOpportunistic infections are an important cause of morbidity and mortality in persons infe...
Infection with the human immunodeficiency virus (HIV-1) results in a severe immunodeficiency charact...
The prognostic value of CD4 counts and RNA viral load for identifying treatment need in HIV-infected...
Background: Markers are needed for assessing response to antiretroviral therapy over t ime. The CD4+...
Human immunodeficiency virus (HIV)-1 DNA and RNA levels and T lymphocyte cell surface markers were m...
The causal relationship between HIV-specific CD4+ T-cell responses and viral control and the effect ...
textabstractBackground: The prognostic value of CD4 counts and RNA viral load for identifying treatm...
Background. Variability in human immunodeficiency virus (HIV) disease progression cannot be fully pr...
This paper is aimed at providing a comprehensive review of markers, cofactors and staging systems us...
DEPLETION OF CD4 CELLS IS Ahallmark of progressive hu-man immunodeficiency vi-rus (HIV) disease1 and...
Background Treatment strategies for patients in whom HIV replication is not suppressed after exposur...
Background: Measures of CD4 T-cell count and HIV-1 plasma viral load before antiretroviral therapy a...